Casopitant, a neurokinin-1 receptor antagonist with anti-emetic and anti-nausea activities
{{output}}
Casopitant, an inhibitor of the neurokinin-1 receptor, and its mesylate salt, are being developed by GlaxoSmithKline plc for the potential treatment of chemotherapy-induced nausea and vomiting (CINV), post-operative nausea and vomiting (PONV), as well as for a... ...
